Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-24 @ 5:09 PM
NCT ID:
NCT01234350
Eligibility Criteria:
Inclusion Criteria:
* Diagnosed with prostate cancer and indicated for androgen deprivation therapy (ADT)
* Decision made to prescribe ADT prior to enrolment
* Willing and able to provide written informed consent
Exclusion Criteria:
* Participation in an interventional clinical study in which any treatment or follow-up is mandated
* Treatment with a GnRH receptor antagonist other than FIRMAGON
* Had previous or is currently under hormonal management of prostate cancer, except for subjects who have undergone therapy with curative intention where neoadjuvant/adjuvant therapy allowed for maximum 6 months. Treatment should be terminated at least 6 months prior to baseline.
Healthy Volunteers:
False
Sex:
MALE
Study:
NCT01234350
Study Brief:
Protocol Section:
NCT01234350